Neurobiology of addiction

Reward Pathway - The Brain's Highway

• The brain's primary reward circuit, crucial for survival behaviors (e.g., eating, sex). Drugs of abuse hijack this system.
• Key Structures & Pathway (Mesolimbic Pathway):
  • Ventral Tegmental Area (VTA): Produces dopamine.
  • Nucleus Accumbens (NAc): Receives dopamine; the "pleasure center."
  • Prefrontal Cortex (PFC): Modulates behavior based on rewards.
• Neurotransmitter: Dopamine (DA) is the principal currency of reward.
• Mechanism of Addiction:
  • Drugs artificially surge dopamine in the NAc, creating intense euphoria.
  • This reinforces drug-seeking behavior, leading to compulsive use.

⭐ All known drugs of abuse, directly or indirectly, increase dopamine transmission in the Nucleus Accumbens. This is the final common pathway for reward and addiction.

Neuroadaptation - The Brain's New Normal

• Chronic substance exposure forces the brain to adapt, establishing a new, pathological "normal." This involves two key processes:

  • Reward System Downregulation: The brain's "Go" system weakens.

    • Sustained high dopamine levels lead to a compensatory ↓ in D2 receptor density and sensitivity.
    • This results in tolerance (needing more drug for the same effect) and a blunted response to natural pleasures (anhedonia).

  • Anti-Reward System Upregulation: The brain's "Stop" system gets overactive.

    • Stress systems, like corticotropin-releasing factor (CRF), are hyperactivated.
    • This drives the negative emotional state of withdrawal (dysphoria, anxiety), promoting drug-seeking to alleviate these symptoms (negative reinforcement).

⭐ The transition from impulsive (pleasure-seeking) to compulsive (habit-driven, avoiding withdrawal) drug use is the clinical hallmark of neuroadaptation in addiction. These brain changes can be long-lasting, underlying the chronic, relapsing nature of the disorder.

Beyond Dopamine - The Supporting Cast

• Glutamate: The "GO" signal for craving.
  • Drives addiction-related learning (neuroplasticity) via NMDA & AMPA receptors.
  • Intensifies drug-seeking behavior and relapse risk.
  • Activity is ↑ in the prefrontal cortex (PFC) → nucleus accumbens pathway.
• GABA (γ-Aminobutyric Acid): The primary "STOP" signal.
  • Chronic substance use ↓ GABAergic inhibition, leading to tolerance.
  • Withdrawal results in unopposed CNS excitation (anxiety, irritability, seizures).
• Norepinephrine (NE): Mediates the physical stress of withdrawal.
  • Hyperactivity of the locus coeruleus causes autonomic arousal (↑ HR, BP, sweating).
• Endogenous Opioids: Contribute to the hedonic effects (euphoria) of drug use.

⭐ Glutamate-driven neuroplasticity is the final common pathway for relapse triggered by drug cues, stress, or re-exposure, making it a critical target for novel pharmacotherapies.

Genetics & Environment - Nature Meets Nurture

• Heritability: ~40-60% of addiction risk is genetic, varying by substance.
• Key Gene Polymorphisms:
  • Dopamine system: DRD2 (D₂ receptor), DAT1 (transporter).
  • Opioid system: OPRM1 (mu-opioid receptor).
  • Alcohol metabolism: ADH1B, ALDH2.
• Epigenetics: Environment (e.g., stress) alters gene expression via mechanisms like methylation.
• Gene-Environment Interaction (GxE):
  • Adverse childhood experiences (ACEs) & peer exposure amplify genetic risk.
  • Protective factors (e.g., strong family support, policy) can buffer this risk.

⭐ Certain ALDH2 variants, common in East Asian populations, cause a flushing reaction to alcohol, acting as a strong protective factor against alcohol use disorder.

High‑Yield Points - ⚡ Biggest Takeaways

• Addiction hijacks the mesolimbic dopamine pathway, connecting the VTA to the Nucleus Accumbens (NAc).
• All drugs of abuse ultimately increase dopamine in the NAc, reinforcing drug-seeking behavior.
• Chronic use causes neuroadaptation (e.g., D2 receptor downregulation), leading to tolerance and anhedonia.
• Impaired prefrontal cortex (PFC) function underlies the loss of executive control and compulsive use.
• The amygdala and hippocampus mediate cue-induced craving, driving relapse.